ACS Headquarters, 28th Floor
633 N. Saint Clair St.
Chicago, IL 60601
Exhibits will be located in ACS Headquarters, on the 28th floor. All meals, coffee breaks, and the reception will also be held in this area.
Choose from one of the exhibit options below and reserve a space by January 30, 2026.
$2,500 exhibit fee includes:
$5,000 exhibit fee includes:
Additional registrations are available to industry exhibitors for $400 each.
Please note:
Please contact Dana McClure, Meetings and Exhibits Coordinator, at dmcclure@facs.org or 312-202-5532 for more information
Exhibit Setup* | 11:00 am–12:00 pm
Exhibit Hours | 12:00–6:00 pm
Exhibit Hours | 7:00 am–5:00 pm
Exhibit Tear Down** | 5:15–6:00 pm
*Exhibits must be staffed during the exhibit hours. Any space not occupied by 12:00 pm on Tuesday, March 10, 2026, will be forfeited by the exhibitor.
**Displays may not be dismantled or any packing begun before 5:15 p.m. on Wednesday, March 11, 2026.
Written notification of a space cancellation must be received by ACS on or before January 30, 2026, to be eligible for a refund. A $500 service charge will be assessed for each canceled space. No refunds will be given after January 30, 2026.
The performance of this Agreement by either party is subject to acts of God, war, government regulation, disaster, fire, epidemic, threatened or imminent strikes, civil disorder, curtailment of transportation facilities, threats or terrorist attacks, or other similar occurrence beyond the control of the parties, making it illegal, impossible, or commercially impractical to carry on the Summit or fully perform the terms of this Agreement. This Agreement may be terminated, or performance may be excused without penalty, for any one or more of such reasons by written notice from one party to the other.
Exhibitors must abide by all applicable Food and Drug Administration (FDA) regulations, including but not limited to any or all approved requirements. Exhibitors are reminded that the FDA prohibits the advertising or other promotion of investigational or unapproved drugs and devices and forbids the promotion of approved drugs or devices for unapproved uses. For additional information, please contact the FDA at 888-463-6332 or visit fda.gov.